{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:51:25Z","timestamp":1792547485355,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PTJ-162167"],"award-info":[{"award-number":["PTJ-162167"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.canlet.2024.216805","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T16:18:17Z","timestamp":1709914697000},"page":"216805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The mast cell-T lymphocyte axis impacts cancer: Friend or foe?"],"prefix":"10.1016","volume":"588","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-8063","authenticated-orcid":false,"given":"Vinicius","family":"Kannen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.216805_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01930779","article-title":"Ueber Eiter- und Bindegewebsk\u00f6rperchen","volume":"28","author":"Recklinghausen","year":"1863","journal-title":"Archiv f. Pathol. Anat."},{"key":"10.1016\/j.canlet.2024.216805_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02933937","article-title":"Beitr\u00e4ge zur Kenntniss der Anilinf\u00e4rbungen und ihrer Verwendung in der mikroskopischen Technik","volume":"13","author":"Ehrlich","year":"1877","journal-title":"Archiv. f. Mikrosk. Anat."},{"key":"10.1016\/j.canlet.2024.216805_bib3","article-title":"New perspectives on the origins and heterogeneity of mast cells","author":"St John","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/216659a0","article-title":"The thymus and the precursors of antigen reactive cells,","volume":"216","author":"Miller","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216805_bib5","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210646","article-title":"No social distancing in the immune system","volume":"218","author":"Miller","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans","volume":"17","author":"Vely","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-4800(74)90059-8","article-title":"Mast cells: extended lifespan and lack of granule turnover under normal in vivo conditions","volume":"20","author":"Padawer","year":"1974","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.canlet.2024.216805_bib8","first-page":"225","article-title":"Production and life span of cutaneous mast cells in young rats","volume":"128","author":"Kiernan","year":"1979","journal-title":"J. Anat."},{"key":"10.1016\/j.canlet.2024.216805_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1365-2362.2003.01152.x","article-title":"Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma","volume":"33","author":"Ribatti","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216805_bib10","doi-asserted-by":"crossref","first-page":"794974","DOI":"10.3389\/fimmu.2022.794974","article-title":"Autocrine\/Paracrine loop between SCF(+)\/c-Kit(+) mast cells promotes cutaneous melanoma progression","volume":"13","author":"Annese","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I","article-title":"Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue","volume":"189","author":"Nielsen","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.216805_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1080\/0284186X.2016.1198493","article-title":"High tumor mast cell density is associated with longer survival of colon cancer patients","volume":"55","author":"Mehdawi","year":"2016","journal-title":"Acta Oncol."},{"key":"10.1016\/j.canlet.2024.216805_bib13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jcmm.12073","article-title":"High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression","volume":"17","author":"Malfettone","year":"2013","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib14","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/ijc.31613","article-title":"Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer","volume":"143","author":"Mao","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib15","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1158\/1078-0432.CCR-11-0607","article-title":"Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma","volume":"17","author":"Chang","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216805_bib16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1649","article-title":"Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors","volume":"13","author":"Soucek","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib17","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-09-1230","article-title":"Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression","volume":"16","author":"Strouch","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216805_bib18","doi-asserted-by":"crossref","first-page":"1969075","DOI":"10.1080\/2162402X.2021.1969075","article-title":"Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response","volume":"10","author":"Cao","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2024.216805_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004653","article-title":"Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition","volume":"10","author":"Sakita","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib20","article-title":"Elevated mast cell abundance is associated with enrichment of CCR2+ cytotoxic T cells and favorable prognosis in lung adenocarcinoma","author":"Fan","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216805_bib21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells,","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216805_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fimmu.2015.00394","article-title":"Mast cells as regulators of T cell responses","volume":"6","author":"Bulfone-Paus","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib23","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3389\/fimmu.2020.01389","article-title":"IL33 and mast cells-the key regulators of immune responses in gastrointestinal cancers?","volume":"11","author":"Eissmann","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib25","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1073\/pnas.0501912102","article-title":"Mast cells enhance T cell activation: importance of mast cell-derived TNF","volume":"102","author":"Nakae","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.216805_bib26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","article-title":"Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity","volume":"40","author":"Galli","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coi.2018.06.006","article-title":"Mast cells and basophils in allergic inflammation","volume":"54","author":"Kubo","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2332\/allergolint.13-RAI-0650","article-title":"Allergen immunotherapy and tolerance","volume":"62","author":"Matsuoka","year":"2013","journal-title":"Allergol. Int."},{"key":"10.1016\/j.canlet.2024.216805_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226701","article-title":"Allergic inflammation is initiated by IL-33-dependent crosstalk between mast cells and basophils","volume":"15","author":"Hsu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.216805_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12016-017-8646-z","article-title":"Role of mast cells in regulation of T cell responses in experimental and clinical settings","volume":"54","author":"Elieh Ali Komi","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-022-09673-3","article-title":"Mast cell marker gene signature in head and neck squamous cell carcinoma","volume":"22","author":"Cai","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jlb.64.6.791","article-title":"Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells","volume":"64","author":"Dimitriadou","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2024.216805_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jlb.66.1.105","article-title":"MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation","volume":"66","author":"Poncet","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2024.216805_bib34","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.4049\/jimmunol.151.11.6318","article-title":"Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma","volume":"151","author":"Frandji","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/cimm.1994.1272","article-title":"Rat peritoneal mast cells present antigen to a PPD-specific T cell line","volume":"158","author":"Fox","year":"1994","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000234998","article-title":"Intrathyroidal mast cells express major histocompatibility complex class-II antigens","volume":"90","author":"Banovac","year":"1989","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib37","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.4049\/jimmunol.0803180","article-title":"Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation","volume":"182","author":"Kambayashi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib38","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2009-02-202648","article-title":"Cell-cell cooperation at the T helper cell\/mast cell immunological synapse","volume":"114","author":"Gaudenzio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216805_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/cimm.1995.1096","article-title":"Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte\/macrophage colony-stimulating factor and downregulation by interferon-gamma","volume":"163","author":"Frandji","year":"1995","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib40","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/eji.1830261036","article-title":"Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes","volume":"26","author":"Frandji","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib41","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib42","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1038\/ncomms7174","article-title":"Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence","volume":"6","author":"Joulia","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216805_bib43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12016-015-8498-3","article-title":"OX40, OX40L and autoimmunity: a comprehensive review","volume":"50","author":"Webb","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2008.08.018","article-title":"CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction","volume":"29","author":"Gri","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216805_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2012.03.032","article-title":"Modulation of FcepsilonRI-dependent mast cell response by OX40L via fyn, PI3K, and RhoA","volume":"130","author":"Sibilano","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib46","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2009-05-220004","article-title":"Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40\/OX40L axis toward Th17-cell differentiation","volume":"114","author":"Piconese","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216805_bib47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.1102389","article-title":"Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-beta","volume":"188","author":"Ganeshan","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav0216","article-title":"MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection","volume":"5","author":"Arifuzzaman","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2024.216805_bib49","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1073\/pnas.1105079108","article-title":"Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance","volume":"108","author":"St John","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.216805_bib50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10620-018-5015-6","article-title":"Mast cells and serotonin synthesis modulate chagas disease in the colon: clinical and experimental evidence","volume":"63","author":"Kannen","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canlet.2024.216805_bib51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/eji.201545879","article-title":"CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice","volume":"46","author":"Gonzalez Roldan","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib52","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/jid.2010.412","article-title":"Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160","volume":"131","author":"Ortonne","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2024.216805_bib53","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1172\/JCI122530","article-title":"Immune synapses between mast cells and gammadelta T cells limit viral infection","volume":"129","author":"Mantri","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216805_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"9","author":"Bertolini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.216805_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.immuni.2012.04.013","article-title":"Critical role for mast cells in interleukin-1beta-driven skin inflammation associated with an activating mutation in the nlrp3 protein","volume":"37","author":"Nakamura","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216805_bib56","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature05010","article-title":"Mast cells are essential intermediaries in regulatory T-cell tolerance","volume":"442","author":"Lu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216805_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4049\/jimmunol.1001183","article-title":"IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression","volume":"186","author":"Eller","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib58","doi-asserted-by":"crossref","first-page":"752350","DOI":"10.3389\/fcell.2021.752350","article-title":"Mast cells as important regulators in autoimmunity and cancer development","volume":"9","author":"Noto","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2024.216805_bib59","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.4049\/jimmunol.175.7.4167","article-title":"Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance","volume":"175","author":"Kawakami","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042249","article-title":"The multifaceted roles of mast cells in immune homeostasis, infections and cancers,","volume":"23","author":"Sobiepanek","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.216805_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12636","article-title":"Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity?","volume":"282","author":"Frossi","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2024.216805_bib62","doi-asserted-by":"crossref","first-page":"605958","DOI":"10.3389\/fimmu.2020.605958","article-title":"Reverse signaling by MHC-I molecules in immune and non-immune cell types","volume":"11","author":"Muntjewerff","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2017.05.029","article-title":"Human mast cells as antigen-presenting cells: when is this role important in vivo?","volume":"141","author":"Galli","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib64","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cellsig.2014.01.029","article-title":"CD1d expressed in mast cell surface enhances IgE production in B cells by up-regulating CD40L expression and mediator release in allergic asthma in mice","volume":"26","author":"Hong","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2024.216805_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.atherosclerosis.2018.11.027","article-title":"Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis","volume":"280","author":"Kritikou","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.canlet.2024.216805_bib66","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.4049\/jimmunol.0901471","article-title":"Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells","volume":"183","author":"Jones","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib67","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1242\/jcs.114.2.323","article-title":"Secretory granules of mast cells accumulate mature and immature MHC class II molecules","volume":"114","author":"Vincent-Schneider","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2024.216805_bib68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaci.2008.10.040","article-title":"Notch signaling confers antigen-presenting cell functions on mast cells","volume":"123","author":"Nakano","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib69","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/dxp048","article-title":"Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma","volume":"21","author":"Ito","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib70","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1091\/mbc.8.12.2631","article-title":"Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation","volume":"8","author":"Raposo","year":"1997","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2024.216805_bib71","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.4049\/jimmunol.176.4.2238","article-title":"Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF","volume":"176","author":"Nakae","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib72","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2007-07-102111","article-title":"Indirect involvement of allergen-captured mast cells in antigen presentation","volume":"111","author":"Kambayashi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216805_bib73","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.177.9.5791","article-title":"Harboring of particulate allergens within secretory compartments by mast cells following IgE\/FcepsilonRI-lipid raft-mediated phagocytosis","volume":"177","author":"Shin","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2567.1999.00789.x","article-title":"FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells","volume":"97","author":"Tkaczyk","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2024.216805_bib75","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2567.1998.00525.x","article-title":"Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation","volume":"94","author":"Tkaczyk","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2024.216805_bib76","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.161.6.2731","article-title":"Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation","volume":"161","author":"Maurer","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib77","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.170.6.3037","article-title":"Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo","volume":"170","author":"Skokos","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib78","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4049\/jimmunol.166.2.868","article-title":"Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes","volume":"166","author":"Skokos","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/path.5285","article-title":"Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis","volume":"249","author":"Sakita","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.216805_bib80","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tem.2020.04.008","article-title":"The dual role of serotonin in colorectal cancer,","volume":"31","author":"Kannen","year":"2020","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.canlet.2024.216805_bib81","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1007\/s00018-014-1642-z","article-title":"The contribution of neuronal-glial-endothelial-epithelial interactions to colon carcinogenesis,","volume":"71","author":"Garcia","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2024.216805_bib82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxlet.2016.11.020","article-title":"A critical discussion on diet, genomic mutations and repair mechanisms in colon carcinogenesis,","volume":"265","author":"Sakita","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.canlet.2024.216805_bib83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrc.2017.122","article-title":"A matter of life and death: stem cell survival in tissue regeneration and tumour formation,","volume":"18","author":"Soteriou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib84","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2019.03.025","article-title":"Adaptive immune resistance emerges from tumor-initiating stem cells","volume":"177","author":"Miao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216805_bib85","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.1038\/s41598-022-17950-1","article-title":"Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer","volume":"12","author":"Cecil","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.216805_bib86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12865-016-0167-7","article-title":"Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model","volume":"17","author":"Wu","year":"2016","journal-title":"BMC Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib88","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000129","article-title":"Paradoxical interaction between cancer and long-term postsepsis disorder: impairment of de novo carcinogenesis versus favoring the growth of established tumors","volume":"8","author":"Leite","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib89","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/eji.201444915","article-title":"RORgammat(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice","volume":"45","author":"Martin","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib90","first-page":"101253","article-title":"Mast cell modulates tumorigenesis caused by repeated bowel inflammation condition in azoxymethane\/dextran sodium sulfate-induced colon cancer mouse model","volume":"30","author":"Lee","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.canlet.2024.216805_bib91","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/2326-6066.CIR-17-0424","article-title":"Mast cell-dependent CD8(+) T-cell recruitment mediates immune surveillance of intestinal tumors in apc(min\/+) mice","volume":"6","author":"Bodduluri","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2024.216805_bib92","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41467-020-20600-7","article-title":"Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy","volume":"12","author":"Somasundaram","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216805_bib93","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2024.216805_bib95","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12016-019-08753-w","article-title":"Role of mast cells in shaping the tumor microenvironment","volume":"58","author":"Komi","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib96","first-page":"296","article-title":"Mast cells stimulated with peptidoglycan from Staphylococcus aureus augment the development of Th1 cells","volume":"21","author":"Matsui","year":"2018","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.canlet.2024.216805_bib97","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2009.08.022","article-title":"Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions","volume":"31","author":"Stelekati","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216805_bib98","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4049\/jimmunol.176.2.857","article-title":"Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis","volume":"176","author":"Yamada","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib99","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pros.23280","article-title":"Low intratumoral mast cells are associated with a higher risk of prostate cancer recurrence","volume":"77","author":"Hempel","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2024.216805_bib100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2017.04.009","article-title":"Mast cells in breast cancer angiogenesis","volume":"115","author":"Cimpean","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2024.216805_bib101","doi-asserted-by":"crossref","first-page":"1189520","DOI":"10.3389\/fimmu.2023.1189520","article-title":"Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib102","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12672-023-00784-2","article-title":"Comparative analysis of single-cell transcriptome reveals heterogeneity in the tumor microenvironment of lung adenocarcinoma and brain metastases","volume":"14","author":"Liang","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.canlet.2024.216805_bib103","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3389\/fimmu.2018.02506","article-title":"The pro-tumorigenic IL-33 involved in antitumor immunity: a Yin and Yang cytokine,","volume":"9","author":"Fournie","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib104","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12307-014-0152-8","article-title":"The role of mast cells in molding the tumor microenvironment,","volume":"8","author":"Rigoni","year":"2015","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.canlet.2024.216805_bib105","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaci.2018.10.054","article-title":"Mast cells as protectors of health","volume":"144","author":"Dudeck","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib106","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1158\/0008-5472.CAN-16-1602","article-title":"IL33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment","volume":"77","author":"Fang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216805_bib107","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fimmu.2017.00424","article-title":"Are mast cells MASTers in cancer?","volume":"8","author":"Varricchi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib108","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.it.2007.03.003","article-title":"Mast cells\u2013key effector cells in immune responses","volume":"28","author":"Metz","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.molimm.2014.02.020","article-title":"Mast cells as targets for immunotherapy of solid tumors","volume":"63","author":"Oldford","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib110","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1038\/ncomms14017","article-title":"A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis,","volume":"8","author":"Moretti","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216805_bib111","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI115330","article-title":"Mast cell tryptase is a mitogen for cultured fibroblasts","volume":"88","author":"Ruoss","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216805_bib112","doi-asserted-by":"crossref","first-page":"20531","DOI":"10.1038\/srep20531","article-title":"Activated mast cells promote differentiation of B cells into effector cells","volume":"6","author":"Palm","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.216805_bib113","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri2018","article-title":"Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data","volume":"7","author":"Bischoff","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib114","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1158\/2326-6066.CIR-14-0102","article-title":"Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment","volume":"3","author":"Danelli","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2024.216805_bib115","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41388-019-1078-x","article-title":"The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-alpha\/IL-33\/ST2L signaling promotes gastric cancer metastasis,","volume":"39","author":"Zhou","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.216805_bib116","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41467-019-10676-1","article-title":"IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization","volume":"10","author":"Eissmann","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216805_bib117","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/gutjnl-2016-312779","article-title":"A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach,","volume":"67","author":"Petersen","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2024.216805_bib118","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1158\/2326-6066.CIR-17-0218","article-title":"Interleukin 33 signaling restrains sporadic colon cancer in an interferon-gamma-dependent manner","volume":"6","author":"Eissmann","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2024.216805_bib119","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41385-019-0176-y","article-title":"The IL-33\/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer,","volume":"12","author":"Pastille","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib120","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1062966","article-title":"The IL-33\/ST2 pathway contributes to intestinal tumorigenesis in humans and mice,","volume":"5","author":"Mertz","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2024.216805_bib121","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2017.03.026","article-title":"Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine\/paracrine signaling of the adenosine A3 receptor","volume":"397","author":"Gorzalczany","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216805_bib122","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1504729","article-title":"Human mast cells promote colon cancer growth via bidirectional crosstalk: studies in 2D and 3D coculture models","volume":"7","author":"Yu","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2024.216805_bib123","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2010.11.010","article-title":"Mast cells, angiogenesis, and tumour growth","volume":"1822","author":"Ribatti","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2024.216805_bib124","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2008-03-147033","article-title":"SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment","volume":"112","author":"Huang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216805_bib125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40425-019-0530-3","article-title":"Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-alpha-PD-L1 pathway","volume":"7","author":"Lv","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.yexcr.2014.11.014","article-title":"Tryptase, a novel angiogenic factor stored in mast cell granules","volume":"332","author":"Ribatti","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2024.216805_bib127","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317699133","article-title":"The role of sphingosine-1-phosphate in the tumor microenvironment and its clinical implications,","volume":"39","author":"Nakajima","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.canlet.2024.216805_bib128","first-page":"705169","article-title":"Tumor-associated mast cells in thyroid cancer","volume":"2015","author":"Visciano","year":"2015","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.canlet.2024.216805_bib129","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1038\/onc.2016.442","article-title":"Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K-->AKT-->GSK3beta-->AM signaling","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.216805_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060834","article-title":"Mast cell tryptase contributes to pancreatic cancer growth through promoting angiogenesis via activation of angiopoietin-1","volume":"17","author":"Guo","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.216805_bib131","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib132","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2009.01.044","article-title":"Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects","volume":"123","author":"Detoraki","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib133","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yexcr.2017.07.033","article-title":"Spatial distribution of mast cells and macrophages around tumor glands in human breast ductal carcinoma","volume":"359","author":"Tamma","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2024.216805_bib134","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02899064","article-title":"Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia","volume":"57","author":"Kitagawa","year":"1989","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"10.1016\/j.canlet.2024.216805_bib135","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/JTO.0b013e3181989ddb","article-title":"Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor","volume":"4","author":"Ali","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2024.216805_bib136","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3402\/ljm.v2i1.4689","article-title":"Significance of neo-angiogenesis and immuno-surveillance cells in squamous cell carcinoma of the tongue","volume":"2","author":"Alkhabuli","year":"2007","journal-title":"Libyan J. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib137","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3748\/wjg.v11.i8.1210","article-title":"Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer","volume":"11","author":"Tan","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2024.216805_bib138","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.ejca.2015.08.014","article-title":"Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983","volume":"51","author":"Tanis","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib139","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230570","article-title":"Landscape of mast cell populations across organs in mice and humans","volume":"220","author":"Tauber","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib140","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb7221","article-title":"Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation","volume":"6","author":"Dwyer","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib141","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00005-016-0408-8","article-title":"The hidden side of disodium cromolyn: from mast cell stabilizer to an angiogenic factor and antitumor agent,","volume":"64","author":"Cimpean","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.canlet.2024.216805_bib142","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41467-017-00327-8","article-title":"Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B","volume":"8","author":"Wroblewski","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216805_bib143","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.18632\/oncotarget.3074","article-title":"Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia","volume":"6","author":"Cerny-Reiterer","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.216805_bib144","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13046-019-1118-y","article-title":"Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment","volume":"38","author":"Xu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216805_bib145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jmedgenet-2018-105610","article-title":"Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations","volume":"57","author":"Helgadottir","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.canlet.2024.216805_bib146","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaci.2020.12.654","article-title":"PD-L1 on mast cells suppresses effector CD8(+) T-cell activation in the skin in murine contact hypersensitivity","volume":"148","author":"Hirano","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib147","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00262-022-03282-6","article-title":"PD-1(+) mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy","volume":"72","author":"Li","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2024.216805_bib148","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216805_bib149","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216805_bib150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41419-019-1611-4","article-title":"Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells","volume":"10","author":"Ndreshkjana","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216805_bib151","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression","volume":"25","author":"Segovia","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib152","doi-asserted-by":"crossref","first-page":"656738","DOI":"10.3389\/fonc.2021.656738","article-title":"mTOR\/EGFR\/iNOS\/MAP2K1\/FGFR\/TGFB1 are druggable candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), with consequent anticancer implications","volume":"11","author":"Lawal","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2024.216805_bib153","doi-asserted-by":"crossref","first-page":"741697","DOI":"10.3389\/fphar.2021.741697","article-title":"A dual PI3K\/HDAC inhibitor downregulates oncogenic pathways in hematologic tumors in vitro and in vivo,","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2024.216805_bib154","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1073\/pnas.1818210116","article-title":"Cancer stemness, intratumoral heterogeneity, and immune response across cancers","volume":"116","author":"Miranda","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.216805_bib155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40425-017-0270-1","article-title":"Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer","volume":"5","author":"Donaldson","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib156","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jdermsci.2017.07.018","article-title":"9-Phenanthrol enhances the generation of an CD8(+) T cell response following transcutaneous immunization with imiquimod in mice","volume":"87","author":"Hartmann","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.canlet.2024.216805_bib157","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.cell.2022.03.023","article-title":"Modular design of synthetic receptors for programmed gene regulation in cell therapies","volume":"185","author":"Zhu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216805_bib158","doi-asserted-by":"crossref","first-page":"871390","DOI":"10.3389\/fonc.2022.871390","article-title":"Human tumor targeted cytotoxic mast cells for cancer immunotherapy","volume":"12","author":"Fereydouni","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2024.216805_bib159","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41591-023-02404-6","article-title":"CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results","volume":"29","author":"Park","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib160","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1182\/bloodadvances.2023009789","article-title":"A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials,","volume":"7","author":"Silbert","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2024.216805_bib161","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.xcrm.2023.101133","article-title":"Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A *02:01 patients with advanced soft tissue sarcoma","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib162","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.aak9510","article-title":"Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer","volume":"356","author":"Stevanovic","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.216805_bib163","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.216805_bib164","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-cell transfer therapy targeting mutant KRAS in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib165","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-018-0040-8","article-title":"Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer","volume":"24","author":"Zacharakis","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.216805_bib166","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-13-0006","article-title":"T cells expressing chimeric antigen receptors can cause anaphylaxis in humans","volume":"1","author":"Maus","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2024.216805_bib167","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2014.01.018","article-title":"Mast cell progenitors: origin, development and migration to tissues","volume":"63","author":"Dahlin","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib168","doi-asserted-by":"crossref","first-page":"154661","DOI":"10.1016\/j.prp.2023.154661","article-title":"Different patterns of mast cell distribution in B-cell non-Hodgkin lymphomas","volume":"248","author":"Guidolin","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.canlet.2024.216805_bib169","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/1097-0142(19881201)62:11<2416::AID-CNCR2820621128>3.0.CO;2-4","article-title":"Prognostic significance of mast cells in soft tissue sarcoma","volume":"62","author":"Ueda","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2024.216805_bib170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216805_bib171","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11882-018-0786-6","article-title":"Mast cell interactions and crosstalk in regulating allergic inflammation","volume":"18","author":"Velez","year":"2018","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.canlet.2024.216805_bib172","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1742-2094-9-222","article-title":"Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results","volume":"9","author":"Hasan","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.canlet.2024.216805_bib173","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-022-05023-2","article-title":"Spatially resolved clonal copy number alterations in benign and malignant tissue","volume":"608","author":"Erickson","year":"2022","journal-title":"Nature"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:43:32Z","timestamp":1760816612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524001988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":173,"alternative-id":["S0304383524001988"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216805","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mast cell-T lymphocyte axis impacts cancer: Friend or foe?","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216805"}}